__NUXT_JSONP__("/drugs/Refametinib", (function(a,b){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"923032-37-5",chebiId:"",chemicalFormula:"C19H20F3IN2O5S",definition:"An orally bioavailable selective MEK inhibitor with potential antineoplastic activity. Refametinib specifically inhibits mitogen-activated protein kinase kinase 1 (MAP2K1 or MAPK\u002FERK kinase 1), resulting in inhibition of growth factor-mediated cell signaling and tumor cell proliferation. MEK, a dual specificity threonine\u002Ftyrosine kinase, is a key component of the RAS\u002FRAF\u002FMEK\u002FERK signaling pathway that regulates cell growth; constitutive activation of this pathway has been implicated in many cancers.",fdaUniiCode:"JPX07AFM0N",identifier:"C74059",preferredName:a,semanticType:"Pharmacologic Substance",subclassOf:["C129825","C69145"],synonyms:["BAY 869766","BAY86-9766","MEK Inhibitor RDEA119","RDEA119","REFAMETINIB",a]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FRefametinib",extension:".json",createdAt:b,updatedAt:b}}],fetch:{},mutations:void 0}}("Refametinib","2021-10-30T13:44:18.563Z")));